Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Haematologica|July 20, 2023
Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugsHiroyuki Takamatsu, Tomohiro Matsuda, Shohei Mizuno, et al.Cytotherapy|June 24, 2023
Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myelomaYosuke Okada, Fumihiko Kimura, Naoki Kurita, et al.Journal of Hematology|September 9, 2024
Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic AnemiaHirofumi Yokota, Kotaro Miyao, Masashi Sawa, et al.International Journal of Hematology|March 1, 2026
Five-year interim analysis of J-SKI: an observational study of TKI discontinuation in patients with CML in JapanNaoto Takahashi, Shinya Kimura, Eri Matsuki, et al.Cancer Medicine|December 8, 2022
CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphomaJunya Yamaguchi, Fumiharu Ohka, Chalise Lushun, et al.Bone Marrow Transplantation|March 24, 2020
Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndromeSeitaro Terakura, Tetsuya Nishida, Masashi Sawa, et al.International Journal of Hematology|March 29, 2024
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016-2021)Hirohiko Shibayama, Mitsuhiro Itagaki, Hiroshi Handa, et al.Frontiers in Oncology|November 21, 2025
Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron eraAkinao Okamoto, Masahiro Yoshida, Senji Kasahara, et al.Pageof 6